Clinical trials
Phase 2 Hodgkin Disease trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University College, London | 5 |
| Bristol-Myers Squibb | 2 |
| Merck Sharp & Dohme LLC | 2 |
| University of Birmingham | 2 |
| ADC Therapeutics S.A. | 1 |
| King's College Hospital NHS Trust | 1 |
| Newcastle-upon-Tyne Hospitals NHS Trust | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 15 |
| Lymphoma | 5 |
| Leukemia, Myeloid, Acute | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Myelodysplastic Syndromes | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Multiple Myeloma | 2 |
| Bronchiolitis Obliterans Syndrome | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.